日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antibody responses to polymorphic Plasmodium falciparum merozoite antigens in Malawian children with severe and uncomplicated malaria

马拉维重症和非重症疟疾患儿对恶性疟原虫裂殖子多态性抗原的抗体反应

Dobaño, Carlota; Rogerson, Stephen J; Cavanagh, David R; Taylor, Terrie E; McBride, Jana S

The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY

2020 年 IUPHAR/BPS 药理学指南:扩展免疫药理学内容并推出 IUPHAR/MMV 疟疾药理学指南

Armstrong, Jane F; Faccenda, Elena; Harding, Simon D; Pawson, Adam J; Southan, Christopher; Sharman, Joanna L; Campo, Brice; Cavanagh, David R; Alexander, Stephen P H; Davenport, Anthony P; Spedding, Michael; Davies, Jamie A

Antibody responses to P. falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso

布基纳法索疟疾流行区儿童对恶性疟原虫血期抗原的抗体反应及临床疟疾发病率

Cherif, Mariama K; Ouédraogo, Oumarou; Sanou, Guillaume S; Diarra, Amidou; Ouédraogo, Alphonse; Tiono, Alfred; Cavanagh, David R; Michael, Theisen; Konaté, Amadou T; Watson, Nora L; Sanza, Megan; Dube, Tina J T; Sirima, Sodiomon B; Nebié, Issa

Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas

针对 GLURP R2、MSP1 block 2 杂交体和 AS202.11 的抗体水平与生活在疟疾高流行区(布基纳法索)和低流行区(加纳)的儿童患疟疾的风险之间的关系

Adu, Bright; Cherif, Mariama K; Bosomprah, Samuel; Diarra, Amidou; Arthur, Fareed K N; Dickson, Emmanuel K; Corradin, Giampietro; Cavanagh, David R; Theisen, Michael; Sirima, Sodiomon B; Nebie, Issa; Dodoo, Daniel

Seroepidemiology of Plasmodium species infections in Zimbabwean population

津巴布韦人群中疟原虫感染的血清流行病学

Amanfo, Seth A; Mduluza, Takafira; Midzi, Nicholas; Cavanagh, David R; Mutapi, Francisca

Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.

对新型恶性疟原虫裂殖子表面蛋白疫苗的抗体反应与夜猴对实验性疟疾感染的保护作用相关

Cavanagh David R, Kocken Clemens H M, White John H, Cowan Graeme J M, Samuel Kay, Dubbeld Martin A, Voorberg-van der Wel Annemarie, Thomas Alan W, McBride Jana S, Arnot David E

Diversity covering AMA1-MSP119 fusion proteins as malaria vaccines

涵盖AMA1-MSP119融合蛋白作为疟疾疫苗的多样性

Faber, Bart W; Younis, Sumera; Remarque, Edmond J; Rodriguez Garcia, Roberto; Riasat, Vanessa; Walraven, Vanessa; van der Werff, Nicole; van der Eijk, Marjolein; Cavanagh, David R; Holder, Anthony A; Thomas, Alan W; Kocken, Clemens H M

Immunological consequences of antihelminthic treatment in preschool children exposed to urogenital schistosome infection

学龄前儿童接触泌尿生殖道血吸虫感染后接受驱虫治疗的免疫学后果

Rujeni, Nadine; Nausch, Norman; Midzi, Nicholas; Cowan, Graeme J; Burchmore, Richard; Cavanagh, David R; Taylor, David W; Mduluza, Takafira; Mutapi, Francisca

Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development

干扰体外寄生虫生长的恶性疟原虫19千道尔顿裂殖子表面蛋白1 (MSP1) 特异性抗体可以抑制MSP1的加工、裂殖子入侵和细胞内寄生虫发育。

Moss, David K; Remarque, Edmond J; Faber, Bart W; Cavanagh, David R; Arnot, David E; Thomas, Alan W; Holder, Anthony A

A malaria vaccine based on the polymorphic block 2 region of MSP-1 that elicits a broad serotype-spanning immune response.

一种基于 MSP-1 多态性 2 区段的疟疾疫苗,可引发广泛的跨血清型免疫反应

Cowan Graeme J M, Creasey Alison M, Dhanasarnsombut Kelwalin, Thomas Alan W, Remarque Edmond J, Cavanagh David R